Wolverine Pen is a pre filled dual peptide blend combining BPC-157 (30mg) and TB-500 (20mg) in a single convenient adjustable dose injection pen. Researched for accelerated tissue and tendon repair, muscle healing, joint recovery, gastrointestinal health, angiogenesis, and systemic anti inflammatory support. 50mg total peptide content with precise adjustable dosing, no reconstitution required.
FormatPre Filled Pen
Concentration30mg BPC-157, 20mg TB-500
Package Selected: 5 Pack Special
Pay with Interac e-Transfer or Crypto
HPLC verified. COA on file for this batch
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
The Wolverine Pen is a dual peptide blend combining BPC-157 and TB-500 into a single 50mg prefilled pen delivery system pairing the two most frequently co studied peptides in tissue repair and regenerative research into one structured, ready to use formulation. F40 Biotech’s prefilled pen format eliminates the individual reconstitution and preparation steps required when sourcing each compound separately, delivering consistent pre measured doses across extended research protocols without preparation variability between administrations.
BPC-157 and TB-500 represent the most established dual peptide combination in regenerative research precisely because their mechanisms are complementary rather than overlapping. BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from gastric juice protein that promotes angiogenesis through nitric oxide pathway modulation, upregulates growth hormone receptors in injured tissue, and activates the FAK paxillin pathway driving cell migration and wound healing. A mechanism profile centered on vascular development and growth factor signaling in damaged tissue. TB-500 (Thymosin Beta-4) is a synthetic analogue of a naturally occurring peptide involved in actin regulation, operating primarily through upregulation of actin polymerization and cell motility pathways that enhance cellular migration to injury sites, modulate inflammatory response, and support new blood vessel formation through a distinct angiogenic mechanism from BPC-157’s nitric oxide pathway. The combination of these two complementary angiogenic and tissue repair mechanisms has made BPC-157 and TB-500 the most referenced peptide pairing in preclinical tissue repair literature.
The Wolverine Pen’s 50mg dual blend sits alongside the Glow Pen’s 130mg triple blend in CSD’s prefilled pen peptide range; both featuring BPC-157 and TB-500 as core components, with the Glow Pen adding GHK-Cu’s extracellular matrix remodeling activity for a three mechanism research profile. Researchers selecting between the two can source the focused dual BPC-157/TB-500 mechanism through the Wolverine Pen or the expanded triple compound regenerative profile through the Glow Pen, with both individual compounds also available separately across multiple formats in CSD’s full peptide range.
F40 Biotech formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity across both peptide components before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and F40 Biotech’s Wolverine Pen meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Store at 2–8°C away from direct light. Do not freeze. Keep upright. Intended for research purposes only.
Commonly researched in tissue repair, tendon and ligament healing, and regenerative biology research contexts. Browse CSD’s full peptide range for complete sourcing.
No reviews yet — be the first to review Wolverine Pen 50mg (BPC157 / TB500).
Good to know
Frequently asked questions
The Wolverine Pen is a pre filled adjustable dose injection pen containing the most extensively co researched tissue repair peptide combination available! BPC-157 (Body Protection Compound 157, 30mg) and TB-500 (Thymosin Beta-4, 20mg) in a single convenient pen format. The two compounds operate through complementary and synergistic tissue repair mechanisms. BPC-157 through growth hormone receptor upregulation, VEGF mediated angiogenesis, and nitric oxide system modulation; TB-500 through actin regulation, cell migration promotion, and angiogenesis stimulation. Their combined effect produces significantly greater tissue repair outcomes than either compound alone, making the BPC-157 + TB-500 stack the most studied peptide combination for musculoskeletal injury recovery, joint repair, and systemic healing research.
BPC-157 and TB-500 address tissue repair through distinct but complementary mechanisms, producing synergistic effects when combined that exceed what either compound achieves alone. BPC-157 works primarily through local tissue mechanisms. Upregulating growth hormone receptors, stimulating VEGF mediated angiogenesis at the injury site, and modulating nitric oxide production for vasodilation and tissue oxygenation. TB-500 works more systemically through actin regulation and cell migration. Promoting the movement of repair cells to injury sites, stimulating new blood vessel formation, and modulating inflammation throughout the body. Together they provide both local tissue repair stimulation from BPC-157 and systemic repair cell mobilization from TB-500; covering both the local and systemic dimensions of tissue healing simultaneously.
The BPC-157 + TB-500 combination is researched across the broadest range of tissue repair applications of any peptide stack. Tendon and ligament repair where both compounds demonstrate particularly strong regenerative effects on connective tissue, muscle fiber repair and recovery from acute muscle injury, joint cartilage and synovial tissue research, gastrointestinal tract healing including gut permeability and mucosal repair from BPC-157's gastric peptide origin, wound healing and scar tissue reduction through combined angiogenesis stimulation, bone repair through growth factor upregulation, and neurological recovery through BPC-157's CNS protective and dopaminergic modulating effects alongside TB-500's neuroprotective properties.
The Wolverine Pen is administered subcutaneously using a standard pen needle, typically in the abdomen, thigh, or upper arm, or locally near the injury site for targeted tissue repair research. Common research doses range from 250mcg to 1mg of the blend per injection administered once or twice daily. The adjustable dose mechanism allows precise titration. Researchers can start at conservative doses and escalate based on individual response. For acute injury research, twice daily administration maintains more consistent plasma peptide levels throughout the day. For general recovery and systemic repair research, once daily morning administration is the most commonly studied schedule. Attach a fresh needle before each injection and dispose safely after use.
Yes! This batch has been independently HPLC tested by an accredited third party laboratory confirming compound identity and concentration accuracy for both active components. BPC-157 30mg and TB-500 20mg, within the 50mg total blend. A certificate of analysis is available.